About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Houston | 462 Studies

Clinical Trials Colorectal CancerHouston

Colorectal Cancer Clinical Trials in Houston

Find 462 clinical trials for colorectal cancer near Houston, Texas. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 401-420 of 462 trials

Active not recruitingCirculating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal CancerThis phase II trial studies circulating cell-free tumor DNA testing to guide treatment with regorafenib or TAS-102 in patients with colorectal cancer that has spread to other…NCT03844620·Houston, Texas Active not recruitingLY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal CancerThis phase Ib/II trial investigates the side effects and best dose of LY3214996 when given together with cetuximab alone or in combination with abemaciclib and to see how well…NCT04616183·Houston, Texas

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedStudy of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesThis is a phase I/II, non randomized, open-label, dose escalation study to investigate the safety, tolerability and preliminary efficacy of CB-103.NCT03422679·Santa Monica, California and 16 others

RecruitingBBO-11818 in Adult Subjects With KRAS Mutant CancerA first in human study to evaluate the safety and preliminary antitumor activity of BBO-11818, a pan-KRAS inhibitor, in subjects with locally advanced unresectable or metastatic…NCT06917079·Los Angeles, California and 16 others

TerminatedOpen-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesThe purpose of the Study is to select a dose and assess the safety and tolerability of INCB057643 as a monotherapy (Part 1 and Part 2) and in combination with standard-of-care…NCT02711137·Birmingham, Alabama and 17 others

TerminatedComparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal CancerRATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer.NCT00062023·Houston, Texas

CompletedA Phase 1 Study of KBP-5209 in Patients With Advanced Solid TumorsThe purpose of this study is to determine the maximum tolerated dose of KBP-5209 as a single agent when given orally to adult patients with advanced solid tumors that have…NCT02442414·Indianapolis, Indiana and 2 others

Active not recruitingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersTTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase 2 dose of TTX-080 monotherapy…NCT04485013·Tucson, Arizona and 40 others

RecruitingA First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS MutationsA first in human study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of BLU-924 / SAR449336, a pan-KRAS inhibitor, in participants with advanced…NCT07629960·Sarasota, Florida and 15 others

UnknownStudy of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid TumorsStudy of NGM438 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid TumorsNCT05311618·Denver, Colorado and 5 others

RecruitingIDOV-Immune for Advanced Solid TumorsThis is a Phase I clinical trial evaluating an investigational treatment called IDOV-Immune, a type of oncolytic virus therapy, for adults with advanced solid tumors that have not…NCT06910657·St Louis, Missouri and 4 others

Recruiting177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsThis is a Phase 1/2a dose escalation and expansion study to determine the safety, tolerability, and preliminary clinical activity of 177LuBetaBart, a lutetium-labeled anti-B7-H3…NCT07189871·Dothan, Alabama and 4 others

RecruitingCollection of Samples USOPTIVAL StudyA prospective multi-center observational study.NCT04792684·Chula Vista, California and 15 others

TerminatedPhase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsA Phase I/II study of autologous T cells engineered using the Sleeping Beauty transposon/transposase system to express TCR(s) reactive against neoantigens in subjects with…NCT05194735·Houston, Texas

Active not recruitingSX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 TrialThis phase Ib/II trial studies the side effects and best dose of SX-682 that can be given alone and in combination with nivolumab in treating patients with RAS-Mutated…NCT04599140·Houston, Texas

RecruitingA Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab MonotherapyThis study is an open-label Phase Ib (Part A) dose escalation followed by a blinded, randomized, multi cohort Phase 2a (Part B) comparison of combination vs. reference regimens.NCT06362369·Aurora, Colorado and 4 others

Active not recruitingPhase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal CancerThis is a multi-center, non-randomised Phase 1b study to evaluate the safety and tolerability of ATP128 alone or in combination with BI 754091 and of heterologous prime-boost…NCT04046445·Scottsdale, Arizona and 11 others

CompletedCancer Prevention and Treatment Demonstration for Ethnic and Racial MinoritiesThe goal of this behavioral research study is to improve the use of cancer prevention services, increase early detection, and treatment of cancer.NCT00453661·Houston, Texas

Not yet recruitingIKS04 Regimen in Advanced Solid Tumors That Express CA242This study will evaluate the safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of the IKS04 Regimen and identify a recommended phase…NCT07738939·Los Angeles, California and 3 others

Active not recruitingStudy of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS MutationThe purpose of this study is to assess 2 different doses of onvansertib to select the lowest dose that is maximally effective, and to assess the safety, efficacy…NCT06106308·Phoenix, Arizona and 40 others

PreviousPage 21 of 24Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma